摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

甘油单异硬脂酸盐 | 50486-18-5

中文名称
甘油单异硬脂酸盐
中文别名
一异硬脂酸甘油酯;单异十八烷酸与1,2,3-丙三醇的酯化物
英文名称
glycerol monoisostearate
英文别名
glyceryl isostearate;isostearic acid monoglyceride;glyceryl monoiso-stearate;glyceryl monoisostearate;monoglyceryl isostearate;glycerol isostearate;2,3-Dihydroxypropyl 16-methylheptadecanoate
甘油单异硬脂酸盐化学式
CAS
50486-18-5;66085-00-5
化学式
C21H42O4
mdl
——
分子量
358.562
InChiKey
ASKIVFGGGGIGKH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 物理描述:
    Liquid

计算性质

  • 辛醇/水分配系数(LogP):
    7.1
  • 重原子数:
    25
  • 可旋转键数:
    19
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.95
  • 拓扑面积:
    66.8
  • 氢给体数:
    2
  • 氢受体数:
    4

SDS

SDS:399ce10689689e7032c0b7e365cb7ad6
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Pharmaceutical composition for transdermal administration
    摘要:
    本发明涉及一种用于经皮给药的药物组合物,其特征在于它包括:a)可选的聚合物释放基质,能够在干燥后形成柔性薄膜,选择自纤维素聚合物或共聚物或乙烯基吡咯烷酮/醋酸乙烯酯共聚物;b)活性成分;c)促进活性成分经皮吸收的促进剂;d)生理上可接受的非水溶剂,能够溶解释放基质、活性成分和经皮吸收促进剂,并且在接触皮肤时能够通过蒸发迅速去除。
    公开号:
    US06010716A1
  • 作为产物:
    描述:
    异十八酸盐酸4-二甲氨基吡啶N,N'-二环己基碳二亚胺 作用下, 以 四氯化碳 为溶剂, 反应 0.17h, 生成 甘油单异硬脂酸盐
    参考文献:
    名称:
    Synthesis of 1-Monoglycerides Having C11-20 Branched Chain Fatty Acids and Their Hemolysis Effects.
    摘要:
    DOI:
    10.7164/antibiotics.52.345
点击查看最新优质反应信息

文献信息

  • SKIN COSMETIC
    申请人:Kao Corporation
    公开号:US20160235641A1
    公开(公告)日:2016-08-18
    The present invention provides a skin cosmetic containing the following components (A), (B), (C), (D), (E), and (F): (A) 0.5 to 6 mass % of a linear saturated fatty acid having 12 to 22 of carbon atom, (B) 0.010 to 5 mass % of an organic base, (C) 0.010 to 1 mass % of an inorganic base, (D) 0.5 to 6 mass % of a linear saturated alcohol having 12 to 22 of carbon atom, (E) 0.05 to 9 mass % of a powder, and (F) water, wherein the component (D) comprises at least a linear saturated alcohol having 12 to 20 of carbon atom, and the mass ratio of the component (E) to the total amount of the components (A) and (D) [(A)+(D)] is (E)/[(A)+(D)]=from 0.01 to 5.
    本发明提供了一种皮肤化妆品,其包含以下组分(A)、(B)、(C)、(D)、(E)和(F):(A) 0.5至6质量%的线性饱和脂肪酸,其碳原子数为12至22,(B) 0.010至5质量%的有机碱,(C) 0.010至1质量%的无机碱,(D) 0.5至6质量%的线性饱和醇,其碳原子数为12至22,(E) 0.05至9质量%的粉末,以及(F) 水,其中组分(D)至少包括一种碳原子数为12至20的线性饱和醇,且组分(E)与组分(A)和(D)的总量的质量比[(A)+(D)]为(E)/[(A)+(D)]=0.01至5。
  • CLEANSING COMPOSITION
    申请人:KAO CORPORATION
    公开号:US20150328127A1
    公开(公告)日:2015-11-19
    The present invention provides a cleansing composition comprising the following components (A), (B), and (C): (A) 0.001 to 5% by mass of a polymer selected from the group consisting of (A-1), (A-2), and (A-3): (A-1) an acrylic copolymer comprising 10 mol % or more of a monomer selected from the group consisting of an acrylic acid alkyl ester and a methacrylic acid alkyl ester, as represented by mol % based on the total monomers; (A-2) a polysaccharide derivative having a polyoxyalkylene chain having an average molecular weight of 300 to 100,000; and (A-3) a polyether polycarbonate; (B) 1 to 50% by mass of one or two or more oil agents selected from the group consisting of (b1) and (b2): (b1) an ether oil and (b2) a hydrocarbon oil having a viscosity of 18 mPa·s or lower at 30° C.; and (C) water, and comprising (D) no nonionic surfactant having HLB of 8 or more or less than 5% by mass of the nonionic surfactant.
    本发明提供了一种清洁组合物,包括以下组分(A)、(B)和(C):(A)选择自(A-1)、(A-2)和(A-3)组成的聚合物中的0.001至5%的质量百分比:(A-1)丙烯酸烷基酯和甲基丙烯酸烷基酯中选择10摩尔%或更多的单体,以摩尔%表示基于总单体;(A-2)具有平均分子量为300至100,000的聚氧烷基链的多糖衍生物;和(A-3)聚醚碳酸酯;(B)从(b1)和(b2)组成的油剂中选择一种或两种或更多种,其中(b1)是醚油,(b2)是在30℃下粘度为18 mPa·s或更低的烃类油;和(C)水,且不包括具有HLB值为8或更少的非离子表面活性剂(D)或非离子表面活性剂的质量百分比少于5%。
  • Composition for hair treatment
    申请人:Kao Corporation
    公开号:EP0472184A1
    公开(公告)日:1992-02-26
    A composition for hair treatment such as hair rinse, shampoo, or hair conditioner, contains (a) 0.1 - 10 wt.% of a modified silicone polymer having at least one alkoxy group in the molecule and a melting point of not lower than 30° C, (b) 0.1 - 20 wt.% of a cationic surface active agent, (c) 0.1 - 30 wt.% of an oily or fatty material, (d) 0.1 - 90 wt.% of an organic liquid which is compatible with water and of which molecule has at least one hydroxyl group, and (e) water.
    一种用于头发护理的组合物,例如头发冲洗剂、洗发水或护发素,含有 (a) 0.1 - 10 重量份的改性硅酮聚合物,其分子中至少有一个烷氧基,熔点不低于 30°C;(b) 0.1 - 20 重量份的阳离子表面活性剂,(c) 0.1 - 30 重量份的油性或脂肪物质,(d) 0.1 - 90 重量份的与水相容且分子中至少有一个羟基的有机液体,以及 (e) 水。
  • Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives
    申请人:KYOWA HAKKO KOGYO CO., LTD.
    公开号:EP1166767A2
    公开(公告)日:2002-01-02
    The present invention provides cosmetics comprising (1) hydroxyproline, an N-acylated hydroxyproline derivative or a salt thereof and (2) at least one component selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, high molecular peptides, high molecular polysaccharides, sphingolipids and seaweed extracts.
    本发明提供了包含以下成分的化妆品:(1)羟脯氨酸、N-酰化羟脯氨酸衍生物或其盐;(2)至少一种选自水溶性维生素、油溶性维生素、高分子肽、高分子多糖、鞘脂和海藻提取物的成分。
  • Pharmaceutical Compositions For Oral And Topical Administration
    申请人:IVAX-CR a.s.
    公开号:EP1334717A2
    公开(公告)日:2003-08-13
    A method of increasing viscosity of a pharmaceutical formulation for oral or topical administration comprises the steps of combining: a) an effective amount of one or more hydrophobic active ingredients; b) 5 to 50% of one or more compounds selected from polyglycerol esters of fatty acids of formula (1)         CH2OR-CHOR-CH2O-[CH2CHOR-CH2O-]NCH2-CHOR-CH2OR     (1) wherein n is an integer from 4 to 13 and R is H or CO.R' wherein R' is C8-22 saturated, unsaturated or hydroxylated alkyl and wherein at least one group R is not hydrogen; c) 5 to 50% of one or more compounds selected from polyglycerol esters of fatty acids and/or unsaturated fatty acids of formula (2).         CH2OR-CHOR-CH2O-[CH2CHOR-CH2O]NCH2-CHOR-CH2OR     (2) wherein n is an integer from 0 - 10 and R = H or CO.R" wherein R" is C8-22 saturated, unsaturated or hydroxylated alkyl, and wherein while at least one group R is not hydrogen; d) 5 to 50% of one or more compounds selected from triglyceride macrogol glycerol esters, partial glycerides or fatty acids or macrogol esters of fatty acids in which the average quantity of reacted ethylene oxide in the synthesis of these substances ranges between 50 to 150 mols and concurrently the ratio between components b) and d) is from 0.1 : 1 to 10 : 1;    wherein the above percentages are selected to total 100%;    and wherein upon dilution with water 1:1 by volume the viscosity of the formulation increases by at least 5 times in comparison to the undiluted composition.
    一种增加口服或局部用药的药物制剂粘度的方法包括以下步骤: 将以下物质结合起来: a) 有效量的一种或多种疏水性活性成分; b) 5-50%的一种或多种选自式(1)脂肪酸聚甘油酯的化合物 ch2or-chor-ch2o-[ch2chor-ch2o-]nch2-chor-ch2or (1) 其中 n 为 4 至 13 的整数,R 为 H 或 CO.R',其中 R' 为 C8-22 饱和、不饱和或羟基烷基,且至少一个基团 R 不是氢; c) 5-50%的一种或多种选自脂肪酸和/或式(2)不饱和脂肪酸的聚甘油酯的化合物。 ch2or-chor-ch2o-[ch2chor-ch2o]nch2-chor-ch2or (2) 其中 n 为 0-10 的整数,R = H 或 CO.R",其中 R" 为 C8-22 饱和、不饱和或羟基烷基,且至少有一个基团 R 不是氢; d) 5%至 50%的一种或多种选自甘油三酯大环甘油酯、部分甘油酯或脂肪酸或脂肪酸 大环甘油酯的化合物,其中合成这些物质时反应的环氧乙烷的平均量为 50 至 150 摩尔,同时成分 b) 和 d) 之间的比例为 0.1 :1 至 10 : 1; 上述百分比总计为 100%; 用 1:1 体积比的水稀释后,制剂的粘度比未稀释组合物至少增加 5 倍。
查看更多